ReviewGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025
Illuminating eye care: the promise and future of red light therapy in ophthalmology.
Review in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Exploring the efficacy of repeated low-level red-light therapy in retarding childhood myopia progression: updated systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
- Repeated low-level red-light therapy for improving asthenopic symptoms and accommodation in presbyopia.Annals of medicine · 2026Trial
- Evaluating the educational quality and reliability of YouTube videos on red light therapy for eye diseases.Lasers in medical science · 2026Article
- Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Cataract Surgery: A Prospective Double-Masked Randomized Controlled Clinical Trial.Ophthalmology and therapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the rapid global rise of myopia, glaucoma, AMD, and dry eye disease, red light therapy (RLT) is quickly emerging as a non-invasive, breakthrough approach with extraordinary potential to transform eye health management. Originally applied for wound healing and pain relief, RLT has shown remarkable, multi-faceted effects in ophthalmology: slowing myopia progression, protecting retinal cells in glaucoma, reducing inflammation in AMD, and relieving symptoms of dry eye disease. However, alongside the surge in research interest, questions regarding optimal dosing, safety, and standardization remain pressing. This review summarizes the latest advances of RLT in eye health, explores its mechanisms of action, analyzes safety concerns in clinical applications, and discusses its synergistic potential with existing treatment methods as well as the integration of RLT with artificial intelligence and wearable technologies. In the future, RLT is expected to play a significant role in the management of chronic ocular diseases, but its long-term effects and safety need careful evaluation, with challenges also remaining in regulatory policies and clinical standardization.
Indexed as
Identifiers
40105942What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.